Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2016 /
Connections in cancer-host immune signalling

9th - 12th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.07.16
Views: 1913
Rating:

Dr Alan Serrels - University of Edinburgh, Edinburgh, UK

Dr Serrels speaks with ecancertv at EACR 2016 about the immuno-suppresive tumour microenvironment.

With specific signalling pathways observed in his research into squamous cell skin carcinoma, he predicts similar modulations would be found in other tumour types, and looks forward to clinical trials of combined checkpoint inhibition and FAK pathway targeting.

Prof Margaret Frame talks more about squamous cell carcinoma in an interview here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation